1. Home
  2. CRS vs ASND Comparison

CRS vs ASND Comparison

Compare CRS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRS
  • ASND
  • Stock Information
  • Founded
  • CRS 1910
  • ASND 2006
  • Country
  • CRS United States
  • ASND Denmark
  • Employees
  • CRS N/A
  • ASND N/A
  • Industry
  • CRS Steel/Iron Ore
  • ASND Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRS Industrials
  • ASND Health Care
  • Exchange
  • CRS Nasdaq
  • ASND Nasdaq
  • Market Cap
  • CRS 12.6B
  • ASND 10.6B
  • IPO Year
  • CRS N/A
  • ASND 2015
  • Fundamental
  • Price
  • CRS $278.52
  • ASND $174.75
  • Analyst Decision
  • CRS Strong Buy
  • ASND Strong Buy
  • Analyst Count
  • CRS 3
  • ASND 17
  • Target Price
  • CRS $256.67
  • ASND $222.18
  • AVG Volume (30 Days)
  • CRS 1.2M
  • ASND 432.9K
  • Earning Date
  • CRS 07-31-2025
  • ASND 09-02-2025
  • Dividend Yield
  • CRS 0.29%
  • ASND N/A
  • EPS Growth
  • CRS 168.78
  • ASND N/A
  • EPS
  • CRS 7.05
  • ASND N/A
  • Revenue
  • CRS $2,920,100,000.00
  • ASND $398,509,511.00
  • Revenue This Year
  • CRS $7.08
  • ASND $77.19
  • Revenue Next Year
  • CRS $9.98
  • ASND $75.84
  • P/E Ratio
  • CRS $39.68
  • ASND N/A
  • Revenue Growth
  • CRS 7.38
  • ASND 12.06
  • 52 Week Low
  • CRS $113.53
  • ASND $111.09
  • 52 Week High
  • CRS $282.99
  • ASND $183.00
  • Technical
  • Relative Strength Index (RSI)
  • CRS 71.02
  • ASND 53.60
  • Support Level
  • CRS $265.35
  • ASND $168.01
  • Resistance Level
  • CRS $281.22
  • ASND $179.50
  • Average True Range (ATR)
  • CRS 7.39
  • ASND 6.21
  • MACD
  • CRS -0.99
  • ASND -0.27
  • Stochastic Oscillator
  • CRS 77.85
  • ASND 60.11

About CRS Carpenter Technology Corporation

Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Share on Social Networks: